Bone loss: Therapeutic approaches for preventing bone loss in inflammatory arthritis

AUTOR(ES)

Rehman, Qaiser

FONTE

BioMed Central

RESUMO

Inflammatory arthritides are commonly characterized by localized and generalized bone loss. Localized bone loss in the form of joint erosions and periarticular osteopenia is a hallmark of rheumatoid arthritis, the prototype of inflammatory arthritis. Recent studies have highlighted the importance of receptor activator of nuclear factor-κB ligand (RANKL)-dependent osteoclast activation by inflammatory cells and subsequent bone loss. In this article, we review the pathogenesis of inflammatory bone loss and explore the possible therapeutic interventions to prevent it.

Documentos Relacionados

• Bone loss: Quantitative imaging techniques for assessing bone mass in rheumatoid arthritis
• Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications
• Bone loss: Epidemiology of bone loss
• Preventing antiphospholipid antibody-induced fetal loss: a new idea.
• Bone loss: Factors that regulate osteoclast differentiation - an update